390 related articles for article (PubMed ID: 17241867)
1. Enhanced recruitment of CX3CR1+ T cells by mucosal endothelial cell-derived fractalkine in inflammatory bowel disease.
Sans M; Danese S; de la Motte C; de Souza HS; Rivera-Reyes BM; West GA; Phillips M; Katz JA; Fiocchi C
Gastroenterology; 2007 Jan; 132(1):139-53. PubMed ID: 17241867
[TBL] [Abstract][Full Text] [Related]
2. Exclusive increase of CX3CR1+CD28-CD4+ T cells in inflammatory bowel disease and their recruitment as intraepithelial lymphocytes.
Kobayashi T; Okamoto S; Iwakami Y; Nakazawa A; Hisamatsu T; Chinen H; Kamada N; Imai T; Goto H; Hibi T
Inflamm Bowel Dis; 2007 Jul; 13(7):837-46. PubMed ID: 17285595
[TBL] [Abstract][Full Text] [Related]
3. The role of MAPK in governing lymphocyte adhesion to and migration across the microvasculature in inflammatory bowel disease.
Scaldaferri F; Sans M; Vetrano S; Correale C; Arena V; Pagano N; Rando G; Romeo F; Potenza AE; Repici A; Malesci A; Danese S
Eur J Immunol; 2009 Jan; 39(1):290-300. PubMed ID: 19130554
[TBL] [Abstract][Full Text] [Related]
4. Recruitment of CD16+ monocytes into synovial tissues is mediated by fractalkine and CX3CR1 in rheumatoid arthritis patients.
Yano R; Yamamura M; Sunahori K; Takasugi K; Yamana J; Kawashima M; Makino H
Acta Med Okayama; 2007 Apr; 61(2):89-98. PubMed ID: 17471309
[TBL] [Abstract][Full Text] [Related]
5. Fractalkine and CX3CR1 mediate leukocyte capture by endothelium in response to Shiga toxin.
Zanchi C; Zoja C; Morigi M; Valsecchi F; Liu XY; Rottoli D; Locatelli M; Buelli S; Pezzotta A; Mapelli P; Geelen J; Remuzzi G; Hawiger J
J Immunol; 2008 Jul; 181(2):1460-9. PubMed ID: 18606701
[TBL] [Abstract][Full Text] [Related]
6. The CC chemokine MCP-1 stimulates surface expression of CX3CR1 and enhances the adhesion of monocytes to fractalkine/CX3CL1 via p38 MAPK.
Green SR; Han KH; Chen Y; Almazan F; Charo IF; Miller YI; Quehenberger O
J Immunol; 2006 Jun; 176(12):7412-20. PubMed ID: 16751386
[TBL] [Abstract][Full Text] [Related]
7. Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients.
Danese S; de la Motte C; Sturm A; Vogel JD; West GA; Strong SA; Katz JA; Fiocchi C
Gastroenterology; 2003 May; 124(5):1249-64. PubMed ID: 12730866
[TBL] [Abstract][Full Text] [Related]
8. Viral macrophage inflammatory protein-II and fractalkine (CX3CL1) chimeras identify molecular determinants of affinity, efficacy, and selectivity at CX3CR1.
Davis CN; Zujovic V; Harrison JK
Mol Pharmacol; 2004 Dec; 66(6):1431-9. PubMed ID: 15361546
[TBL] [Abstract][Full Text] [Related]
9. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
[TBL] [Abstract][Full Text] [Related]
10. Involvement of interaction between Fractalkine and CX3CR1 in cytotoxicity of natural killer cells against tumor cells.
Zhang X; Wei H; Wang H; Tian Z
Oncol Rep; 2006 Feb; 15(2):485-8. PubMed ID: 16391873
[TBL] [Abstract][Full Text] [Related]
11. Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis.
Ruth JH; Volin MV; Haines GK; Woodruff DC; Katschke KJ; Woods JM; Park CC; Morel JC; Koch AE
Arthritis Rheum; 2001 Jul; 44(7):1568-81. PubMed ID: 11465708
[TBL] [Abstract][Full Text] [Related]
12. Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow.
Fong AM; Robinson LA; Steeber DA; Tedder TF; Yoshie O; Imai T; Patel DD
J Exp Med; 1998 Oct; 188(8):1413-9. PubMed ID: 9782118
[TBL] [Abstract][Full Text] [Related]
13. Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets.
Schulz C; Schäfer A; Stolla M; Kerstan S; Lorenz M; von Brühl ML; Schiemann M; Bauersachs J; Gloe T; Busch DH; Gawaz M; Massberg S
Circulation; 2007 Aug; 116(7):764-73. PubMed ID: 17679613
[TBL] [Abstract][Full Text] [Related]
14. Enhanced platelet adhesion induces angiogenesis in intestinal inflammation and inflammatory bowel disease microvasculature.
Rutella S; Vetrano S; Correale C; Graziani C; Sturm A; Spinelli A; De Cristofaro R; Repici A; Malesci A; Danese S
J Cell Mol Med; 2011 Mar; 15(3):625-34. PubMed ID: 20158572
[TBL] [Abstract][Full Text] [Related]
15. Fractalkine/CX3CL1 production by human airway smooth muscle cells: induction by IFN-gamma and TNF-alpha and regulation by TGF-beta and corticosteroids.
Sukkar MB; Issa R; Xie S; Oltmanns U; Newton R; Chung KF
Am J Physiol Lung Cell Mol Physiol; 2004 Dec; 287(6):L1230-40. PubMed ID: 15321787
[TBL] [Abstract][Full Text] [Related]
16. Fractalkine upregulates intercellular adhesion molecule-1 in endothelial cells through CX3CR1 and the Jak Stat5 pathway.
Yang XP; Mattagajasingh S; Su S; Chen G; Cai Z; Fox-Talbot K; Irani K; Becker LC
Circ Res; 2007 Nov; 101(10):1001-8. PubMed ID: 17885215
[TBL] [Abstract][Full Text] [Related]
17. Transendothelial migration of CD16+ monocytes in response to fractalkine under constitutive and inflammatory conditions.
Ancuta P; Moses A; Gabuzda D
Immunobiology; 2004; 209(1-2):11-20. PubMed ID: 15481136
[TBL] [Abstract][Full Text] [Related]
18. Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease.
Danese S; Sgambato A; Papa A; Scaldaferri F; Pola R; Sans M; Lovecchio M; Gasbarrini G; Cittadini A; Gasbarrini A
Am J Gastroenterol; 2005 Apr; 100(4):886-95. PubMed ID: 15784037
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of fractalkine and its receptor CX3CR1 in canine inflammatory bowel disease and their possible role in recruitment of intraepithelial lymphocytes.
Maeda S; Ohno K; Nakamura K; Uchida K; Nakashima K; Fukushima K; Nakajima M; Goto-Koshino Y; Fujino Y; Tsujimoto H
Vet Immunol Immunopathol; 2012 Aug; 148(3-4):226-35. PubMed ID: 22648046
[TBL] [Abstract][Full Text] [Related]
20. Expression of CX3CR1 associates with cellular migration, metastasis, and prognosis in human clear cell renal cell carcinoma.
Yao X; Qi L; Chen X; Du J; Zhang Z; Liu S
Urol Oncol; 2014 Feb; 32(2):162-70. PubMed ID: 23570708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
